表紙
市場調査レポート

神経血管/神経インターベンション市場:世界の動向と競合分析

Neurovascular Devices/Interventional Neurology Market by Technology (Embolization, Carotid Stenting, Balloon Angioplasty, Neurothrombectomy), Product (Carotid Stent, Flow Diversion, Microcatheter, Clot Retrieval, Suction Device): Global Forecast to 2020

発行 MarketsandMarkets 商品コード 253839
出版日 ページ情報 英文 166 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
神経血管/神経インターベンション市場:世界の動向と競合分析 Neurovascular Devices/Interventional Neurology Market by Technology (Embolization, Carotid Stenting, Balloon Angioplasty, Neurothrombectomy), Product (Carotid Stent, Flow Diversion, Microcatheter, Clot Retrieval, Suction Device): Global Forecast to 2020
出版日: 2015年10月07日 ページ情報: 英文 166 Pages
概要

神経インターベンション放射線治療または血管神経手術とは、脳や脊髄の血管障害の診断や治療で行われる特に低侵襲の処置です。画像技術の進歩により、マイクロカテーテルを使い、より複雑な疾患の治療が可能になってきています。神経インターベンションデバイスの世界市場は2015年以降、CAGRが8.4%で推移し、2020年には23億7,040万米ドル規模に達する見込みとなっております。

当レポートでは、世界の神経血管/神経インターベンション市場について調査分析を行い、技術別、製品別、地域別に市場を考察するとともに、競合状況、主要企業のプロファイルなどについてまとめてお届けいたします。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場のセグメンテーション
  • 市場のダイナミクス
    • 市場促進要因
    • 市場抑制因子
    • 市場機会
    • 市場の課題
  • 現在進行中の臨床研究

第6章 世界の神経インターベンション装置市場:技術別

  • イントロダクション
  • 塞栓およびコイリング
  • 頚動脈血管造影/頚動脈ステント留置術
  • 支援技術
  • 脳血栓除去

第7章 世界の神経インターベンション装置市場:製品別

  • イントロダクション
  • 動脈瘤コイリング/動静脈先天性異常塞栓
  • 脳バルーン血管形成/ステントシステム
  • 補助装置
  • 脳血栓除去装置

第8章 地域別分析

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • 世界のその他の諸国

第9章 競合状況

  • 概要
  • 市場シェア分析
  • 競合シナリオ
  • 最新動向
    • 新製品の発売と製品強化
    • 地域的拡大
    • 戦略的買収
    • 合意および提携
    • その他の動向

第10章 企業プロファイル

第11章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 1310

The global neurovascular devices/interventional neurology market is poised to reach ~$2,370.4 million by 2020, growing at a CAGR of 8.4% from 2015 to 2020. North America is expected to hold the largest share of 47.3% of the global market in 2015. Market growth is being propelled by growing target patient population, technological advancements in the field of interventional neurosurgeries, favorable medical reimbursement scenario across mature markets, and expanding healthcare infrastructure in developing countries. However, factors such as ongoing healthcare reforms in the U.S. and a dearth of skilled neurosurgeons are restraining the growth of this market. In addition, stringent regulatory policies (that regulate product development and commercialization) across major markets are posing significant challenges for the growth of the neurovascular devices/interventional neurology market during the forecast period.

In this report, the global neurovascular devices/interventional neurology market is segmented on the basis of technology (embolization & coiling, carotid artery angioplasty & stenting, supporting techniques, and neurothrombectomy) and product (cerebral balloon angioplasty & stenting systems, aneurysm coiling & embolization devices, support devices, and neurothrombectomy devices). The aneurysm coiling and embolization devices segment is expected to account for the largest share of the global neurovascular devices/interventional neurology market in 2015, followed by cerebral balloon angioplasty & stenting systems. The cerebral balloon angioplasty & stenting systems segment is expected to grow at the highest CAGR during the next five years owing to factors such as an increasing number of researches, rising public-private funding to develop novel carotid stents & occlusion catheter products, and growing availability of technologically advanced stents & embolic protection devices across major markets (such as Europe, Japan, and the U.S.).

Geographically, North America (comprising the U.S. and Canada) is expected to command the largest share of the global neurovascular devices/interventional neurology market in 2015, followed by Europe. Asia-Pacific is also poised to grow at the highest CAGR during the forecast period, owing to factors such as the presence of a large patient population base for target diseases, rising awareness among neurosurgeons (related to benefits offered by interventional neurology devices during neurosurgery), ongoing government initiatives to modernize & expand respective healthcare infrastructure, and increasing adoption due to decreasing prices of interventional neurology devices in Asia-Pacific.

The global neurovascular devices/interventional neurology market is moderately competitive, with various global as well as local players. In 2014, the global neurovascular devices/interventional neurology devices market was dominated by Stryker Corporation (U.S.), Medtronic, plc (U.S.), Johnson & Johnson (U.S.), Terumo Corporation (Japan), and Penumbra, Inc. (U.S.), which together accounted for ~87.0% of the neurovascular devices/interventional neurology market. Geographic expansion, strategic acquisitions, new product launches, agreements, and collaborations are the major strategies adopted by most market players to achieve growth in the global neurovascular devices/interventional neurology market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis such as market share analysis of the top ten players and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high-growth segments of the neurovascular devices/interventional neurology market, and high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms to garner higher market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the neurovascular devices/interventional neurology products offered by the top 10 players in the global market. The report analyzes the neurovascular devices/interventional neurology market by product, application, and end user across key geographic regions
  • Product Development/Innovation: Detailed insights on upcoming neurovascular devices/interventional neurology technologies, research and development activities, and new product launches in the market
  • Market Development: Comprehensive information on lucrative emerging markets. The report analyzes the markets for various neurovascular devices/interventional neurology products across key geographic regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global neurovascular devices/interventional neurology market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the global neurovascular devices/interventional neurology market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. GEOGRAPHIC SCOPE
    • 1.3.3. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Breakdown of primaries
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. BOTTOM-UP APPROACH
    • 2.2.2. TOP-DOWN APPROACH
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. RESEARCH ASSUMPTIONS
    • 2.4.1. ASSUMPTIONS

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT MARKET SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET OVERVIEW (2015-2020)
  • 4.2. GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY TECHNOLOGY (2015)
  • 4.3. GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT TYPE (2015-2020)
  • 4.4. GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY PRODUCT (2015)
  • 4.5. GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY PRODUCT (UNITS)
  • 4.6. GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY REGION (2015-2020)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. KEY MARKET DRIVERS
      • 5.3.1.1. Growing target patient population
      • 5.3.1.2. Technological advancements
      • 5.3.1.3. Favorable medical reimbursements
      • 5.3.1.4. Expansion of healthcare infrastructure across developing countries
      • 5.3.1.5. Growing market demand for effective neurovascular devices
    • 5.3.2. KEY MARKET RESTRAINTS
      • 5.3.2.1. Ongoing healthcare reforms in the U.S.
      • 5.3.2.2. Dearth of skilled neurosurgeons
    • 5.3.3. KEY MARKET OPPORTUNITIES
      • 5.3.3.1. Growing market penetration of key players in emerging countries
      • 5.3.3.2. Increasing research in neurovascular therapies
      • 5.3.3.3. Rising demand for minimally invasive neurosurgical procedures
    • 5.3.4. KEY MARKET CHALLENGE
      • 5.3.4.1. Stringent regulatory policies
  • 5.4. ONGOING CLINICAL STUDIES
    • 5.4.1. EMBOLIZATION COILING PROCEDURES
    • 5.4.2. CAROTID ARTERY STENTING PROCEDURES
    • 5.4.3. EMBOLIC PROTECTION PROCEDURES
    • 5.4.4. FLOW DIVERSION PROCEDURES
    • 5.4.5. SUPPORTING TECHNIQUES
    • 5.4.6. NEUROTHROMBECTOMY PROCEDURES

6. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY TECHNOLOGY

  • 6.1. INTRODUCTION
  • 6.2. EMBOLIZATION AND COILING
  • 6.3. CAROTID ARTERY ANGIOPLASTY AND STENTING
  • 6.4. SUPPORTING TECHNIQUES
  • 6.5. NEUROTHROMBECTOMY

7. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY PRODUCT 69

  • 7.1. INTRODUCTION
  • 7.2. ANEURYSM COILING AND EMBOLIZATION DEVICES
    • 7.2.1. EMBOLIC COILS
      • 7.2.1.1. Bare Detachable Coils
      • 7.2.1.2. Coated Detachable Coils
    • 7.2.2. FLOW DIVERSION DEVICES
    • 7.2.3. LIQUID EMBOLIC AGENTS
  • 7.3. CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS
    • 7.3.1. CAROTID ARTERY STENTS
    • 7.3.2. EMBOLIC PROTECTION SYSTEMS
      • 7.3.2.1. Distal Filter Devices
      • 7.3.2.2. Balloon Occlusion Devices
  • 7.4. SUPPORT DEVICES
    • 7.4.1. MICROCATHETERS
    • 7.4.2. MICROGUIDEWIRES
  • 7.5. NEUROTHROMBECTOMY DEVICES
    • 7.5.1. CLOT RETRIEVAL DEVICES
    • 7.5.2. SUCTION AND ASPIRATION DEVICES
    • 7.5.3. SNARES

8. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REGION 97

  • 8.1. INTRODUCTION
  • 8.2. NORTH AMERICA
    • 8.2.1. U.S.
  • 8.3. EUROPE
  • 8.4. ASIA-PACIFIC
    • 8.4.1. JAPAN
  • 8.5. REST OF THE WORLD (ROW)

9. COMPETITIVE LANDSCAPE

  • 9.1. OVERVIEW
  • 9.2. MARKET SHARE ANALYSIS
  • 9.3. COMPETITIVE SCENARIO
  • 9.4. RECENT DEVELOPMENTS
    • 9.4.1. NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS
    • 9.4.2. GEOGRAPHICAL EXPANSIONS
    • 9.4.3. STRATEGIC ACQUISITIONS
    • 9.4.4. AGREEMENTS AND PARTNERSHIPS
    • 9.4.5. OTHER DEVELOPMENTS

10. COMPANY PROFILES (Overview, Financials, Products, Strategy, & Developments)*

  • 10.1. INTRODUCTION
    • 10.1.1. GEOGRAPHIC MIX
    • 10.1.2. STRATEGIC BENCHMARKING
  • 10.2. STRYKER CORPORATION
  • 10.3. MEDTRONIC PLC
  • 10.4. JOHNSON & JOHNSON
  • 10.5. TERUMO CORPORATION
  • 10.6. PENUMBRA, INC.
  • 10.7. ABBOTT LABORATORIES
  • 10.8. MERIT MEDICAL SYSTEMS, INC.
  • 10.9. W. L. GORE & ASSOCIATES, INC.
  • 10.10. MICROPORT SCIENTIFIC CORPORATION
  • 10.11. MEDIKIT CO., LTD.

*Details on Financials, Products, Strategy, & Developments might not be captured in case of unlisted companies.

11. APPENDIX

  • 11.1. INSIGHTS OF INDUSTRY EXPERTS
  • 11.2. DISCUSSION GUIDE
  • 11.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 11.4. AVAILABLE CUSTOMIZATIONS
  • 11.5. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: GROWING TARGET PATIENT POPULATION IS RESULTING IN HIGHER MARKET DEMAND FOR NEUROVASCULAR AND INTERVENTIONAL NEUROLOGY PRODUCTS
  • TABLE 2: DEARTH OF SKILLED NEUROSURGEONS HINDERING THE ADOPTION OF NEUROVASCULAR DEVICES AMONG HEALTHCARE PROFESSIONALS
  • TABLE 3: GROWTH POTENTIAL IN EMERGING MARKETS
  • TABLE 4: STRINGENT REGULATORY FRAMEWORK THREATENING OVERALL MARKET GROWTH
  • TABLE 5: EMBOLIZATION COILS: ONGOING CLINICAL TRIALS (AS OF 2015)
  • TABLE 6: CAROTID STENTS: ONGOING CLINICAL TRIALS (AS OF 2015)
  • TABLE 7: DISTAL FILTER AND BALLOON OCCLUSION CATHETERS: ONGOING CLINICAL TRIALS (AS OF 2015)
  • TABLE 8: FLOW DIVERSION DEVICES: ONGOING CLINICAL TRIALS (AS OF 2015)
  • TABLE 9: MICROCATHETERS: ONGOING CLINICAL TRIALS (AS OF 2015)
  • TABLE 10: CLOT RETRIEVAL, SUCTION, AND ASPIRATION DEVICES: ONGOING CLINICAL TRIALS (AS OF 2015)
  • TABLE 11: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 12: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIZATION AND COILING, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 13: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR CAROTID ARTERY ANGIOPLASTY AND STENTING, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 14: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR SUPPORTING TECHNIQUES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 15: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR NEUROTHROMBECTOMY, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 16: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 17: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2013-2020 (UNITS)
  • TABLE 18: ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 19: ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 20: ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 21: EMBOLIC COILS MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 22: EMBOLIC COILS MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 23: EMBOLIC COILS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 24: BARE DETACHABLE COILS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 25: BARE DETACHABLE COILS MARKET SIZE, BY REGION, 2013-2020 (UNITS)
  • TABLE 26: COATED DETACHABLE COILS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 27: COATED DETACHABLE COILS MARKET SIZE, BY REGION, 2013-2020 (UNITS)
  • TABLE 28: FLOW DIVERSION DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 29: ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET VOLUME FOR FLOW DIVERSION DEVICES, BY REGION, 2013-2020 (UNITS)
  • TABLE 30: LIQUID EMBOLIC AGENTS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 31: LIQUID EMBOLIC AGENTS MARKET SIZE, BY REGION, 2013-2020 (UNITS)
  • TABLE 32: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 33: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 34: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 35: CAROTID ARTERY STENTS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 36: CAROTID ARTERY STENTS MARKET SIZE, BY REGION, 2013-2020 (UNITS)
  • TABLE 37: EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 38: EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 39: EMBOLIC PROTECTION DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 40: DISTAL FILTER DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 41: DISTAL FILTER DEVICES MARKET SIZE, BY REGION, 2013-2020 (UNITS)
  • TABLE 42: BALLOON OCCLUSION DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 43: BALLOON OCCLUSION DEVICES MARKET SIZE, BY REGION, 2013-2020 (UNITS)
  • TABLE 44: NEUROVASCULAR AND INTERVENTIONAL NEUROLOGY SUPPORT DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 45: NEUROVASCULAR AND INTERVENTIONAL NEUROLOGY SUPPORT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 46: NEUROVASCULAR AND INTERVENTIONAL NEUROLOGY SUPPORT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 47: NEUROVASCULAR AND INTERVENTIONAL NEUROLOGY MICROCATHETERS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 48: NEUROVASCULAR AND INTERVENTIONAL NEUROLOGY MICROCATHETERS MARKET SIZE, BY REGION, 2013-2020 (UNITS)
  • TABLE 49: NEUROVASCULAR AND INTERVENTIONAL NEUROLOGY MICROGUIDEWIRES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 50: NEUROVASCULAR AND INTERVENTIONAL NEUROLOGY MICROGUIDEWIRES MARKET SIZE, BY REGION, 2013-2020 (UNITS)
  • TABLE 51: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 52: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (UNITS)
  • TABLE 53: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 54: NEUROTHROMBECTOMY CLOT RETRIEVAL DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 55: NEUROTHROMBECTOMY CLOT RETRIEVAL DEVICES MARKET SIZE, BY REGION, 2013-2020 (UNITS)
  • TABLE 56: NEUROTHROMBECTOMY SUCTION & ASPIRATION DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 57: NEUROTHROMBECTOMY SUCTION & ASPIRATION DEVICES MARKET SIZE, BY REGION, 2013-2020 (UNITS)
  • TABLE 58: NEUROTHROMBECTOMY SNARES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 59: NEUROTHROMBECTOMY SNARES MARKET SIZE, BY REGION, 2013-2020 (UNITS)
  • TABLE 60: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 61: NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 62: NORTH AMERICA: ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 63: NORTH AMERICA: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 64: NORTH AMERICA: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 65: NORTH AMERICA: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 66: U.S.: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 67: EUROPE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 68: EUROPE: ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 69: EUROPE: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 70: EUROPE: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 71: EUROPE: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 72: ASIA-PACIFIC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 73: ASIA-PACIFIC: ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 74: ASIA-PACIFIC: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 75: ASIA-PACIFIC: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 76: ASIA-PACIFIC: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 77: JAPAN: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 78: ROW: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 79: ROW: ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 80: ROW: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 81: ROW: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 82: ROW: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 83: NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS, 2012-2015
  • TABLE 84: GEOGRAPHICAL EXPANSIONS, 2012-2015
  • TABLE 85: STRATEGIC ACQUISITIONS, 2012-2015
  • TABLE 86: AGREEMENTS AND PARTNERSHIPS, 2012-2015
  • TABLE 87: OTHER DEVELOPMENTS, 2012-2015

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BOTTOM-UP APPROACH
  • FIGURE 3: TOP-DOWN APPROACH
  • FIGURE 4: DATA TRIANGULATION
  • FIGURE 5: ASSUMPTIONS FOR THE RESEARCH STUDY
  • FIGURE 6: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 7: FUTURE TRENDS: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY TECHNOLOGY (2015-2020)
  • FIGURE 8: FUTURE TRENDS: NEUROVASCULAR DEVICES AND INTERVENTIONAL NEUROLOGY MARKET SHARE, BY PRODUCT (2015 VS. 2020)
  • FIGURE 9: FUTURE TRENDS: NEUROVASCULAR DEVICES AND INTERVENTIONAL NEUROLOGY PRODUCTS MARKET SIZE, BY TYPE (2015-2020)
  • FIGURE 10: FUTURE TRENDS: CAROTID BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT TYPE (2015-2020)
  • FIGURE 11: FUTURE TRENDS: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SHARE, BY REGION (2015)
  • FIGURE 12: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD
  • FIGURE 13: NORTH AMERICA IS EXPECTED TO DOMINATE THE INTERVENTIONAL NEUROLOGY TECHNOLOGIES MARKET IN 2015
  • FIGURE 14: CAROTID STENTS & FLOW DIVERSION DEVICES SEGMENTS ARE EXPECTED TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD
  • FIGURE 15: ANEURYSM COILING AND EMBOLIZATION DEVICES IS THE KEY PRODUCT SEGMENT ACROSS ALL REGIONS IN 2015
  • FIGURE 16: CAROTID STENTS & FLOW DIVERSION DEVICES ARE POISED TO BE THE FASTEST-GROWING PRODUCT SEGMENTS TILL 2020
  • FIGURE 17: ASIA-PACIFIC IS POISED TO BE THE FASTEST GROWING REGION IN NEUROVASCULAR DEVICE/INTERVENTIONAL NEUROLOGY MARKET TILL 2020
  • FIGURE 18: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 19: PROPORTION OF GERIATRIC POPULATION TO TOTAL POPULATION, BY COUNTRY, (2012 VS. 2020)
  • FIGURE 20: GLOBAL TREND IN GOVERNMENT HEALTHCARE EXPENDITURE: DEVELOPED VS. DEVELOPING COUNTRIES (2010-2012)
  • FIGURE 21: ONGOING CLINICAL TRIALS ACROSS THE GLOBE (AS IN 2015)
  • FIGURE 22: CAROTID ARTERY ANGIOGRAPHY & STENTING IS POISED TO BE THE FASTEST-GROWING NEUROVASCULAR TECHNOLOGY DURING FORECAST PERIOD
  • FIGURE 23: NORTH AMERICA IS EXPECTED TO BE THE LARGEST GEOGRAPHIC SEGMENT IN THE GLOBAL SUPPORTING TECHNIQUES MARKET (2015)
  • FIGURE 24: BALLOON ANGIOGRAPHY & STENTING SYSTEMS MARKET TO WITNESS HIGHEST GROWTH AMONG ALL PRODUCTS CATEGORIES DURING 2015 TO 2020
  • FIGURE 25: EMBOLIC COILS SEGMENT EXPECTED TO LEAD ANEURYSM COILING AND EMBOLIZATION DEVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 26: CAROTID STENTS TO WITNESS HIGHEST GROWTH IN THE CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET
  • FIGURE 27: MICROCATHETERS TO HOLD THE LARGEST SHARE OF SUPPORTING DEVICES MARKET DURING THE STUDY PERIOD
  • FIGURE 28: CLOT RETRIEVERS SEGMENT TO WITNESS SIGNIFICANT GROWTH IN NEUROTHROMBECTOMY DEVICES MARKET
  • FIGURE 29: NORTH AMERICA TO LEAD THE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET DURING 2015-2020
  • FIGURE 30: NORTH AMERICAN MARKET SNAPSHOT: RISING NUMBER OF CLINICAL TRIALS TO AUGMENT THE ADOPTION OF NEUROVASCULAR DEVICES
  • FIGURE 31: EUROPEAN MARKET SNAPSHOT: GROWING AVAILABILITY OF INNOVATIVE NEUROVASCULAR DEVICES TO SUPPORT MARKET GROWTH
  • FIGURE 32: ASIA-PACIFIC MARKET SNAPSHOT: INCREASING LOCALIZED MANUFACTURING TO PROPEL DEMAND FOR NEUROVASCULAR DEVICES
  • FIGURE 33: ROW MARKET SNAPSHOT: LOW AWARENESS LIMITING MARKET EXPANSION
  • FIGURE 34: NEW PRODUCT LAUNCHES & PRODUCT ENHANCEMENTS WAS ADOPTED BY MOST OF THE LEADING PLAYERS TO STRENGTHEN THEIR MARKET POSITIONS BETWEEN 2012 AND 2015
  • FIGURE 35: GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 36: RANKING OF MARKET PLAYERS, BY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SEGMENT (2014)
  • FIGURE 37: CONTINUOUS PRODUCT DEVELOPMENT & COMMERCIALIZATION IS STIMULATING MARKET COMPETITION AMONG KEY PLAYERS
  • FIGURE 38: GEOGRAPHIC REVENUE MIX OF TOP FOUR MARKET PLAYERS*
  • FIGURE 39: LEADING COMPANIES FOCUS ON GEOGRAPHIC EXPANSIONS TO STRENGTHEN THEIR DISTRIBUTION NETWORKS & DEVICE MANUFACTURING CAPABILITIES
  • FIGURE 40: STRYKER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 41: MEDTRONIC PLC: COMPANY SNAPSHOT
  • FIGURE 42: JOHNSON & JOHNSON: COMPANY SNAPSHOT
  • FIGURE 43: TERUMO CORPORATION: COMPANY SNAPSHOT
  • FIGURE 44: ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • FIGURE 45: MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT
  • FIGURE 46: MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
Back to Top